Udayavni Special

J&J seeks permission for clinical trial of single-shot COVID-19 vaccine in India


PTI, Apr 20, 2021, 2:36 PM IST

New Delhi: Global healthcare major Johnson & Johnson on Tuesday said it has sought approval from India’s drug regulator to conduct a bridging clinical trial of its single-dose COVID-19 vaccine in the country.

The US Food and Drug Administration (USFDA) had in February approved Johnson & Johnson’s COVID-19 vaccine that works with just one dose for emergency use.

”Johnson & Johnson is partnering with health authorities and the world’s best scientists to provide the safety and efficacy data necessary to support worldwide emergency use of the Janssen COVID-19 vaccine candidate,” the company said in a statement.

This comes close on the heels of the central government last week deciding to fast-track emergency approvals for all foreign-produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain, or Japan.

Such vaccines will be given emergency use approval mandating the requirement of post-approval parallel bridging clinical trial in place of conduct of local clinical trial under the provisions of the New Drugs and Clinical Trials Rules 2019, the health ministry had said.

”In line with this commitment, we have submitted an application to the Drugs Controller General of India (DCGI) requesting approval to conduct a bridging clinical study of our single-dose Janssen COVID-19 vaccine candidate in India to comply with local regulations”, the statement added.

Johnson & Johnson’s vaccine can be stored at refrigerator temperatures.

So far, two vaccines – one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research – National Institute of Virology – are being used in India.

Both the vaccines are being manufactured within the country by domestic firms. While the Oxford/Astrazeneca vaccine ‘Covishield’ is being manufactured by the Serum Institute of India, the indigenously developed ‘Covaxin’ is being manufactured by Bharat Biotech.

A third vaccine Sputnik V – developed in Russia and to be imported and sold in India by Dr Reddy’s Laboratories – has also been approved by the Indian drug regulator.

The government, meanwhile, on Monday decided to expand its vaccination drive by allowing everyone above 18 years of age to get vaccinated from May 1 and permitted State governments, private hospitals, and industrial establishments to procure the doses directly from manufacturers.

A bridging study is defined as a study performed in the new region to provide pharmacodynamic or clinical data on efficacy, safety, dosage and dose regimen in the new region that will allow extrapolation of the foreign clinical data to the population in the new region.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

COVID-19 patient’s death: Family allege medical negligence, protest in front of Wenlock hospital

Actively monitor private COVID-19 vaccine manufacturers: Kejriwal writes to Vardhan

Vaccination of 18-44 age group: Construction workers, kin to get COVID jab in first phase

‘Younger brother’ Himanta will take Assam to greater heights: outgoing CM Sonowal

Goa: 130 COVID-19 patients shifted to GMCH’s super speciality block

CM Stalin assures transparency, says govt is for all

COVID-19 patient found hanging in Pune hospital, probe on



Related Articles More

Vaccination of 18-44 age group: Construction workers, kin to get COVID jab in first phase

India records 4,03,738 new COVID-19 cases, 2,42,362 deaths

Karnataka reports 47,563 COVID-19 cases, 482 deaths

DCGI approves anti-Covid drug developed by DRDO for emergency use

K’taka districts that may surpass B’luru Urban in COVID-19 cases

MUST WATCH

IPL 2021 : What next? | Udayavani

Udayavani 9 -May -2021 News Bulletin

D. K. Suresh | Covid 2nd Wave | Don’t be afraid of covid. But be warned

Patients Complaints against food at Moodigere Hospital

Police Raid at Vitla Cloth Shop

Latest Additions

COVID-19 patient’s death: Family allege medical negligence, protest in front of Wenlock hospital

Actively monitor private COVID-19 vaccine manufacturers: Kejriwal writes to Vardhan

Vaccination of 18-44 age group: Construction workers, kin to get COVID jab in first phase

‘Younger brother’ Himanta will take Assam to greater heights: outgoing CM Sonowal

Goa: 130 COVID-19 patients shifted to GMCH’s super speciality block

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.